Your browser doesn't support javascript.
loading
RPTOR mutation: a novel predictor of efficacious immunotherapy in melanoma.
Jiang, Yanfang; Hu, Xintong; Wang, Zhouyu; Zhang, Qin; Chen, Dongsheng; Zhao, Pingwei.
Afiliação
  • Jiang Y; Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, 130021, China.
  • Hu X; Genetic Diagnosis Center, The First Hospital of Jilin University, Changchun, 130021, China.
  • Wang Z; Jiangsu Simcere Diagnostics Co.,Ltd, The State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, 210002, China.
  • Zhang Q; Jiangsu Simcere Diagnostics Co.,Ltd, The State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, 210002, China.
  • Chen D; Jiangsu Simcere Diagnostics Co.,Ltd, The State Key Laboratory of Neurology and Oncology Drug Development, Nanjing, 210002, China. dongsheng.chen@simceredx.com.
  • Zhao P; General Surgery Center, The First Hospital of Jilin University, Changchun, 130021, China. zhaopingwei@jlu.edu.cn.
Invest New Drugs ; 42(1): 60-69, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38071684
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Limite: Humans Idioma: En Revista: Invest New Drugs Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China